BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20819433)

  • 1. Effects of ulinastatin and cyclophosphamide on the growth of xenograft breast cancer and expression of CXC chemokine receptor 4 and matrix metalloproteinase-9 in cancers.
    Sun ZJ; Yu T; Chen JS; Sun X; Gao F; Zhao XL; Luo J
    J Int Med Res; 2010; 38(3):967-76. PubMed ID: 20819433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor effects in mice of low-dose (metronomic) cyclophosphamide administered continuously through the drinking water.
    Man S; Bocci G; Francia G; Green SK; Jothy S; Hanahan D; Bohlen P; Hicklin DJ; Bergers G; Kerbel RS
    Cancer Res; 2002 May; 62(10):2731-5. PubMed ID: 12019144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Additive effects of ulinastatin and docetaxel on growth of breast cancer xenograft in nude mice and expression of PGE2, IL-10, and IL-2 in primary breast cancer cells.
    Zhong B; Shen H; Sun X; Wang H; Zhang Y; Sun Z
    Cancer Biother Radiopharm; 2012 May; 27(4):252-8. PubMed ID: 22594905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Jiazhu decoction in combination with cyclophosphamide on breast cancer in mice.
    Guan H; Xie S; Liu S; Xie Q; Hou S; Liu H; Zhang Y; Hu Y; Zhang C
    J Tradit Chin Med; 2019 Oct; 39(5):642-648. PubMed ID: 32186113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ulinastatin exerts synergistic effects with taxotere and inhibits invasion and metastasis of breast cancer by blocking angiogenesis and the epithelial-mesenchymal transition.
    Gao F; Sun Z; Sun X; Zhang Y; Wang H; Zhong B; Luo J; Zhao X
    Cancer Biother Radiopharm; 2013 Apr; 28(3):218-25. PubMed ID: 23477357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ulinastatin reduces the resistance of liver cancer cells to epirubicin by inhibiting autophagy.
    Song B; Bian Q; Shao CH; Li G; Liu AA; Jing W; Liu R; Zhang YJ; Zhou YQ; Hu XG; Jin G
    PLoS One; 2015; 10(3):e0120694. PubMed ID: 25815885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibitory effect of fumagillol combined with cyclophosphamide on metastasis of lung adenocarcinoma cell line LA795 xenograft in mice].
    Wang XH; Wang Z; Duan BC; Song JT; He JB; Ou LW; Zhang P
    Ai Zheng; 2005 Dec; 24(12):1448-52. PubMed ID: 16351790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
    Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
    Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.
    Liang AL; Qian HL; Zhang TT; Zhou N; Wang HJ; Men XT; Qi W; Zhang PP; Fu M; Liang X; Lin C; Liu YJ
    Drug Des Devel Ther; 2015; 9():5671-86. PubMed ID: 26527862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiangiogenic therapy of established tumors in human skin/severe combined immunodeficiency mouse chimeras by anti-endoglin (CD105) monoclonal antibodies, and synergy between anti-endoglin antibody and cyclophosphamide.
    Takahashi N; Haba A; Matsuno F; Seon BK
    Cancer Res; 2001 Nov; 61(21):7846-54. PubMed ID: 11691802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitization of human breast cancer cells to cyclophosphamide and ifosfamide by transfer of a liver cytochrome P450 gene.
    Chen L; Waxman DJ; Chen D; Kufe DW
    Cancer Res; 1996 Mar; 56(6):1331-40. PubMed ID: 8640822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective enrichment of hepatocellular cancer stem cells by chemotherapy.
    Tan S; Chen JS; Sun LJ; Yao HR
    J Int Med Res; 2009; 37(4):1046-56. PubMed ID: 19761687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ulinastatin on the expression and distribution of high mobility group box 1 in human colon carcinoma cells in vitro.
    Wang Y; Tao T; Dong Y; Zhang J; Qin Z
    Mol Med Rep; 2015 Mar; 11(3):2041-7. PubMed ID: 25385285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemokine receptor CXCR4 gene silencing with shRNA inhibits breast cancer metastasis to the lung in nude mice].
    Zhang MX; Han N; Yu SY; Leng Y
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):325-9. PubMed ID: 18953828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dioscorea bulbifera polysaccharide and cyclophosphamide combination enhances anti-cervical cancer effect and attenuates immunosuppression and oxidative stress in mice.
    Cui H; Li T; Wang L; Su Y; Xian CJ
    Sci Rep; 2016 Jan; 5():19185. PubMed ID: 26753518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of estrogen receptors alpha and beta in human breast carcinoma by exogenous leptin in nude mouse xenograft model.
    Yu W; Gu JC; Liu JZ; Wang SH; Wang Y; Zhang ZT; Ma XM; Song MM
    Chin Med J (Engl); 2010 Feb; 123(3):337-43. PubMed ID: 20193256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combined effects of celecoxib and minocycline hydrochloride on inhibiting the osseous metastasis of breast cancer in nude mice.
    Niu G; Liao Z; Cai L; Wei R; Sun L
    Cancer Biother Radiopharm; 2008 Aug; 23(4):469-76. PubMed ID: 18771351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo.
    Wang X; Zhang J; Xu T
    Toxicol Appl Pharmacol; 2007 Jan; 218(1):88-95. PubMed ID: 17156807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling cancer chemoimmunotherapy mechanisms by gene and protein expression profiling of responses to cyclophosphamide.
    Moschella F; Valentini M; Aricò E; Macchia I; Sestili P; D'Urso MT; Alessandri C; Belardelli F; Proietti E
    Cancer Res; 2011 May; 71(10):3528-39. PubMed ID: 21444678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTOR inhibition sensitizes gastric cancer to alkylating chemotherapy in vivo.
    Cejka D; Preusser M; Fuereder T; Sieghart W; Werzowa J; Strommer S; Wacheck V
    Anticancer Res; 2008; 28(6A):3801-8. PubMed ID: 19189667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.